Neuraworx develops bioelectronic technology intended to support cerebrovascular and brain health.
Founded in 2021 and based in Excelsior, US, Neuraworx develops Intelligent Cerebrovascular Pacing™, a bioelectronic system designed to support cerebrovascular function and the glymphatic system. It targets healthcare providers and researchers. In December 2025, the company raised an undisclosed amount led by Nexus NeuroTech Ventures, with Foothill Ventures, Verge HealthTech, and Wisconsin Alumni Research Foundation participating. Funding will support team growth, preclinical testing, and regulatory planning.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in